5432132025-10-012025-12-315432132025-04-012025-12-315432132025-10-012025-12-31in-capmkt:OtherExpenses1Member5432132025-04-012025-12-31in-capmkt:OtherExpenses1Member5432132025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432132025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432132025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15432132025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss25432132025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15432132025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares543213ROSSARINOTLISTEDINE02A801020ROSSARI BIOTECH LIMITEDMain BoardEquity2025-04-012026-03-312026-01-172026-01-09INRMillionsQuarterlyThird quarterSingle segmentManufacturing of Specialty Chemicals for Textile, Home and Personal Care, Performance Chemicals and Animal Health and Nutrition industries2026-01-1712:30:002026-01-1713:30:00Not applicable2025-10-012025-12-31UnauditedConsolidated5816800000509000058218900004175990000109730000-2777100004025600007665000019614000071750000054008600004210300000421030000132080000-348100009727000003237600000003980000327740000-17400003260000003277400000-1740000011076000005.925.91005.925.91Notes:1.The financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on 17th January,2026.2.The consolidated financial results have been prepared in accordance with the recognition and measurement principles laid down under Indian Accounting Standard (Ind AS) 34 on "Interim Financial Reporting" as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.3.The consolidated financial results include the financial results of four foreign subsidiaries - Rossari Global DMCC, Rossari Bangladesh Limited, Rossari International Company Limited and Rossari (Singapore) Pte Ltd (incorporated on 18th December 2025) two step-down foreign subsidiaries - Rossari Biotech Trading FZE and Unistar Thai Co. Ltd., (100% subsidiary of Rossari Global DMCC), four Indian subsidiaries - Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, Buzil Rossari Private Limited and Rossari Consumer Products Private Limited, an associate company - Romakk Chemicals Private Limited and a joint venture company - Hextar Unitop SDN. BHD. (a joint venture company of Unitop Chemicals Private Limited).4.The Group deals in Specialty chemicals and considering that the nature of products and the predominant risk and returns of the products are similar, the Group considers it as one operating segment.5.During the quarter ended 31st December, 2025, the Company has allotted 14,400 equity shares of Rs. 2 each pursuant to exercise of options under the approved Rossari Employee Stock Option Plan - 2019.6."The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four Labour Codes, viz., Code on Wages, 2019, Code on Social Security, 2020, Industrial Relations Code, 2020 and Occupational Safety, Health and Working Conditions Code, 2020 (Collectively referred to as the ‘New Labour Codes’). These codes have been made effective from 21st November, 2025.The Group has estimated the revised gratuity liability as at 31st December 2025 as per the New Labour Codes and the additional liability arising thereon has been recognized as part of employee benefit expense in the current reporting period. No material additional liability on compensated absences and provident fund arose on account of the aforesaid codes.The Government is in the process of notifying related rules to the New Labour Codes and impact of these will be evaluated and accounted for in accordance with applicable accounting standards in the period in which they are notified."7.Previous year/period figures have been regrouped to make them comparable with the current year / period figures, wherever applicable, which are not material. <BR> For ROSSARI BIOTECH LIMITED <BR> SUNIL CHARI <BR> Managing Director <BR> DIN:00149083 <BR> Place : Mumbai <BR> Date :17th January,20262025-04-012025-12-31UnauditedConsolidated17115030000331300001714816000011592100000693180000-5552400001155200000194840000555960000214327000015779310000136885000001368850000453640000-10338000035026000001018590000000138700001032460000-5440000102702000010324600000-54400000110760000018.6518.630018.6518.63Other Expenses717500000Other Expenses2143270000Remeasurements of the defined benefit plans-2870000-2870000Remeasurements of the defined benefit plans-9380000-9380000-720000-2360000Exchange on translation of foreign operations940000Income tax relating to items that will be reclassified to profit or loss-530000410000Exchange on translation of foreign operations2110000Income tax relating to items that will be reclassified to profit or loss-530000158000000-1740000-5440000